Skip to content

Insider · CIK 0001465914

Davis Aaron I.

Reports to the SEC for 9 companies · SOLANA BEACH, CA

Transactions

50

Companies

9

Filings

10

CIK

0001465914

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2024-09-03TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)J Other—
2024-06-11iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2024-01-26Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2024-01-26Rain Oncology Inc.U Disposition from Tender—
2024-01-26Rain Oncology Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2024-01-23Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer—
2024-01-23Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer—
2024-01-23Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer—
2024-01-23Mirati Therapeutics, Inc.D Disposition to Issuer—
2024-01-23Mirati Therapeutics, Inc.D Disposition to Issuer—
2024-01-23Mirati Therapeutics, Inc.D Disposition to Issuer—
2023-12-29Mirati Therapeutics, Inc.A Award+$400K
2023-08-09Rain Oncology Inc.Stock Option (Right to Buy)A Award—
2023-06-13iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2023-06-06TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2023-06-06TNGXTango Therapeutics, Inc.A Award—
2023-01-20Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award—
2023-01-20Mirati Therapeutics, Inc.A Award—
2022-11-04Rain Oncology Inc.Non-Voting Common StockP Purchase+$2.33M
2022-11-04Rain Oncology Inc.P Purchase+$5.67M
2022-06-09iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2022-06-08TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2022-06-01Rain Oncology Inc.Stock Option (Right to Buy)A Award—
2022-05-11iTeos Therapeutics, Inc.S Sale−$6.15M
2022-05-11iTeos Therapeutics, Inc.S Sale−$15.6K
2022-05-10iTeos Therapeutics, Inc.S Sale−$2.4M
2022-05-10iTeos Therapeutics, Inc.S Sale−$120K
2022-05-09iTeos Therapeutics, Inc.S Sale−$573K
2022-05-09iTeos Therapeutics, Inc.S Sale−$4.69M
2022-05-02iTeos Therapeutics, Inc.S Sale−$196K
2022-05-02iTeos Therapeutics, Inc.S Sale−$2.55M
2022-04-29iTeos Therapeutics, Inc.S Sale−$3.11M
2022-04-29iTeos Therapeutics, Inc.S Sale−$282K
2022-04-28iTeos Therapeutics, Inc.S Sale−$4.11M
2022-03-23iTeos Therapeutics, Inc.P Purchase+$657K
2022-03-22iTeos Therapeutics, Inc.P Purchase+$167K
2022-03-22iTeos Therapeutics, Inc.P Purchase+$679K
2022-03-22iTeos Therapeutics, Inc.P Purchase+$122K
2022-01-14Mirati Therapeutics, Inc.A Award—
2022-01-14Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award—
2021-11-19Odonate Therapeutics, Inc.S Sale−$276K
2021-11-19Odonate Therapeutics, Inc.S Sale−$57.5K
2021-11-18Odonate Therapeutics, Inc.S Sale−$487K
2021-11-17Odonate Therapeutics, Inc.S Sale−$1.3M
2021-11-17Odonate Therapeutics, Inc.S Sale−$380K
2021-06-17iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2021-04-27Rain Oncology Inc.Series B Preferred StockC Conversion—
2021-04-27Rain Oncology Inc.P Purchase+$17.4M
2021-04-27Rain Oncology Inc.Series B Preferred StockC Conversion—
2021-04-27Rain Oncology Inc.Non-Voting Common StockC Conversion—